Transcription factor STAT3 as a prognostic marker and therapeutic target in cancer.
Dana-Farber Cancer Institute; Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
David A
DA
Frank
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*
D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human